title: Dispensing processes impact apparent biological activity as determined by computational and statistical analyses.
abstract: Dispensing and dilution processes may profoundly influence estimates of biological activity of compounds. Published data show Ephrin type-B receptor 4 IC50 values obtained via tip-based serial dilution and dispensing versus acoustic dispensing with direct dilution differ by orders of magnitude with no correlation or ranking of datasets. We generated computational 3D pharmacophores based on data derived by both acoustic and tip-based transfer. The computed pharmacophores differ significantly depending upon dispensing and dilution methods. The acoustic dispensing-derived pharmacophore correctly identified active compounds in a subsequent test set where the tip-based method failed. Data from acoustic dispensing generates a pharmacophore containing two hydrophobic features, one hydrogen bond donor and one hydrogen bond acceptor. This is consistent with X-ray crystallography studies of ligand-protein interactions and automatically generated pharmacophores derived from this structural data. In contrast, the tip-based data suggest a pharmacophore with two hydrogen bond acceptors, one hydrogen bond donor and no hydrophobic features. This pharmacophore is inconsistent with the X-ray crystallographic studies and automatically generated pharmacophores. In short, traditional dispensing processes are another important source of error in high-throughput screening that impacts computational and statistical analyses. These findings have far-reaching implications in biological research.
authors: Collaborations in Chemistry, Fuquay-Varina, North Carolina, USA. ekinssean@yahoo.com
authors: Sean
authors: S
authors: Ekins
authors: Joe
authors: J
authors: Olechno
authors: Antony J
authors: AJ
authors: Williams
mesh_terms: D016477:Artifacts; D001665:Binding Sites; D057166:High-Throughput Screening Assays / Q000379:methods*; D006801:Humans; D006860:Hydrogen Bonding; D057927:Hydrophobic and Hydrophilic Interactions; D020128:Inhibitory Concentration 50; D008958:Models, Molecular; D011485:Protein Binding; D047428:Protein Kinase Inhibitors / Q000737:chemistry / Q000494:pharmacology*; D036081:Receptors, Eph Family / Q000037:antagonists & inhibitors / Q000737:chemistry
chemical_list: D047428:Protein Kinase Inhibitors; D036081:Receptors, Eph Family
references: Drug Discov Today. 2011 Sep;16(17-18):747-50
references: 21871970
references: Bioorg Med Chem Lett. 2008 May 1;18(9):2776-80
references: 18434142
references: Drug Discov Today. 2012 Jul;17(13-14):685-701
references: 22426180
references: Bioorg Med Chem Lett. 2011 Apr 15;21(8):2207-11
references: 21441027
references: J Pharmacol Exp Ther. 2002 May;301(2):427-34
references: 11961040
references: Br J Pharmacol. 2007 Sep;152(1):9-20
references: 17549047
references: J Biomol Screen. 2009 Jun;14(5):476-84
references: 19483144
references: J Biomol Screen. 2009 Jun;14(5):566-72
references: 19470712
references: Acta Crystallogr D Biol Crystallogr. 2003 Oct;59(Pt 10):1874-6
references: 14501143
references: Brain Res Bull. 1990 Sep;25(3):433-5
references: 1705471
references: J Chem Inf Model. 2007 Sep-Oct;47(5):1923-32
references: 17691764
references: J Biomol Screen. 2008 Jul;13(6):486-93
references: 18566482
references: Science. 2008 Nov 7;322(5903):917
references: 18988846
references: J Pharmacol Exp Ther. 1994 Feb;268(2):718-26
references: 8113983
references: Clin Chem. 2009 Oct;55(10):1883-4
references: 19617286
references: J Chem Inf Model. 2012 Apr 23;52(4):943-55
references: 22480372
references: Lab Chip. 2010 Jan 7;10(1):13-22
references: 20024044
references: Bioorg Med Chem Lett. 2008 Nov 1;18(21):5717-21
references: 18851911
references: J Biomol Screen. 2009 Jun;14(5):452-9
references: 19498082
references: J Biomol Screen. 2010 Jan;15(1):86-94
references: 20008122
references: Bioorg Med Chem Lett. 2010 Nov 1;20(21):6242-5
references: 20850301